Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 CAD | 0.00% | -2.04% | -17.24% |
Jan. 16 | Vext Science, Inc. Announces Transition of Jason Thai Nguyen Out of Executive Role | CI |
2023 | Vext Science, Inc. Announces Board Changes | CI |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Capitalization 1 | 89.5 | 69.2 | 26.37 | 43.15 | 43.15 | - |
Enterprise Value (EV) 2 | 89.5 | 76.84 | 58.59 | 71.25 | 83.45 | 43.15 |
P/E ratio | 39.5 x | - | - | -12 x | -12 x | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 3.55 x | 1.86 x | 0.74 x | 1.22 x | 0.9 x | 0.64 x |
EV / Revenue | 3.55 x | 2.06 x | 1.65 x | 2.01 x | 1.75 x | 0.64 x |
EV / EBITDA | 13.1 x | 5.74 x | 3.88 x | 10.3 x | 6.22 x | 1.97 x |
EV / FCF | -9.13 x | -10.8 x | -19.9 x | 6.96 x | 21.1 x | 3.36 x |
FCF Yield | -11% | -9.24% | -5.01% | 14.4% | 4.74% | 29.8% |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 115,153 | 136,713 | 148,963 | 245,451 | 245,451 | - |
Reference price 3 | 0.9900 | 0.6400 | 0.2400 | 0.2400 | 0.2400 | 0.2400 |
Announcement Date | 4/15/21 | 4/20/22 | 3/22/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | 25.19 | 37.24 | 35.41 | 35.38 | 47.74 | 67.87 |
EBITDA 1 | 6.813 | 13.39 | 15.12 | 6.891 | 13.42 | 21.89 |
EBIT 1 | 4.686 | - | - | 0.419 | - | - |
Operating Margin | 18.6% | - | - | 1.18% | - | - |
Earnings before Tax (EBT) | 2.639 | - | - | - | - | - |
Net income | 2.125 | - | - | - | - | - |
Net margin | 8.43% | - | - | - | - | - |
EPS 2 | 0.0251 | - | - | -0.0200 | -0.0200 | - |
Free Cash Flow 1 | -9.803 | -7.102 | -2.938 | 10.23 | 3.957 | 12.84 |
FCF margin | -38.91% | -19.07% | -8.3% | 28.93% | 8.29% | 18.92% |
FCF Conversion (EBITDA) | - | - | - | 148.53% | 29.49% | 58.66% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/15/21 | 4/20/22 | 3/22/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 9.376 | 9.4 | 9.308 | 10.79 | 8.766 | 7.673 | 8.181 | 9.111 | 9.187 | 8.099 | 8.975 | 9.642 | 9.674 | 10.91 | 13.87 |
EBITDA 1 | 3.436 | 3.568 | 3.37 | 3.887 | 4.847 | 3.279 | 3.181 | 2.931 | 1.049 | 1.077 | 2.08 | 2.596 | 2.718 | 3.276 | 4.29 |
EBIT | 2.303 | 1.689 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Margin | 24.56% | 17.97% | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | - | - | - | - | - | - | - | - | - | -0.0136 | -0.0100 | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 8/24/21 | 11/18/21 | 4/20/22 | 5/30/22 | 8/24/22 | 11/17/22 | 3/22/23 | 5/25/23 | 8/23/23 | 11/28/23 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 7.64 | 32.2 | 28.1 | 40.3 | - |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 0.57 x | 2.131 x | 4.078 x | 3.004 x | - |
Free Cash Flow 1 | -9.8 | -7.1 | -2.94 | 10.2 | 3.96 | 12.8 |
ROE (net income / shareholders' equity) | 6.86% | 12.8% | 13.6% | 9.7% | 5.4% | - |
ROA (Net income/ Total Assets) | 4.51% | 8.82% | 8.75% | 9% | 6.1% | - |
Assets | 47.12 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share 2 | - | 0.1000 | 0.0600 | 0.0900 | 0.0500 | - |
Capex 1 | 4.06 | 18.8 | 8.86 | 5.22 | 3.71 | 1.86 |
Capex / Sales | 16.13% | 50.43% | 25.02% | 14.74% | 7.78% | 2.75% |
Announcement Date | 4/15/21 | 4/20/22 | 3/22/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.24% | 43.03M | |
+29.90% | 272M | |
+44.86% | 261M | |
+50.00% | 194M | |
+43.48% | 131M | |
-28.57% | 121M | |
+115.91% | 119M | |
-36.75% | 119M | |
0.00% | 86.82M | |
+150.00% | 75.33M |
- Stock Market
- Equities
- VEXT Stock
- Financials Vext Science, Inc.